- Home
- COSM vs TLPH Comparison
COSM vs TLPH Comparison
Compare COSM & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- TLPH
- Stock Information
- Founded
- COSM 2009
- TLPH 2005
- Country
- COSM United States
- TLPH United States
- Employees
- COSM N/A
- TLPH N/A
- Industry
- COSM Other Pharmaceuticals
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- TLPH Health Care
- Exchange
- COSM Nasdaq
- TLPH Nasdaq
- Market Cap
- COSM 12.3M
- TLPH 11.1M
- IPO Year
- COSM 2013
- TLPH 2011
- Fundamental
- Price
- COSM $0.93
- TLPH $0.94
- Analyst Decision
- COSM
- TLPH Strong Buy
- Analyst Count
- COSM 0
- TLPH 1
- Target Price
- COSM N/A
- TLPH $6.00
- AVG Volume (30 Days)
- COSM 477.5K
- TLPH 4.3M
- Earning Date
- COSM 11-13-2025
- TLPH 11-12-2025
- Dividend Yield
- COSM N/A
- TLPH N/A
- EPS Growth
- COSM N/A
- TLPH N/A
- EPS
- COSM N/A
- TLPH N/A
- Revenue
- COSM $55,093,442.00
- TLPH $27,000.00
- Revenue This Year
- COSM $28.14
- TLPH N/A
- Revenue Next Year
- COSM N/A
- TLPH $14,533.26
- P/E Ratio
- COSM N/A
- TLPH N/A
- Revenue Growth
- COSM N/A
- TLPH N/A
- 52 Week Low
- COSM $0.28
- TLPH $0.38
- 52 Week High
- COSM $1.28
- TLPH $1.20
- Technical
- Relative Strength Index (RSI)
- COSM 60.29
- TLPH 75.75
- Support Level
- COSM $0.86
- TLPH $0.88
- Resistance Level
- COSM $1.07
- TLPH $1.20
- Average True Range (ATR)
- COSM 0.10
- TLPH 0.13
- MACD
- COSM 0.02
- TLPH 0.03
- Stochastic Oscillator
- COSM 73.37
- TLPH 62.70
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.